In vitro susceptibility of recent gram-positive isolates to ciprofloxacin, levofloxacin, and trovafloxacin

Diagnostic Microbiology and Infectious Disease

Volumn 32, Issue 2, 1998, Pages 115-118

  Isenberg, Henry D ^a   Alperstein, Phyllis ^a   France, Kenneth ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TROVAFLOXACIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ENTEROCOCCUS FAECALIS; GRAM POSITIVE BACTERIUM; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 0031731555     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(98)00078-9     Document Type: Article

References (12)

1. Brighty K.E., Gootz T.D. The chemistry and biological profile of trovafloxacin. J Antimicrob Chemother. 39:(suppl B):1997;1-14.
2. Davis R., Bryson H.M. Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy. Drugs. 47:1994;677-700.
3. Gootz T.D., Brighty K.E. Fluoroquinolone antibacterials SAR, mechanism of action, resistance and clinical aspects . Med Res Rev. 16:1996;433-486.
4. Isenberg H.D. Clinical Microbiology Procedures Handbook. 1992;American Society for Microbiology, Washington, DC.
5. Just P.M. Overview of the fluoroquinolone antibiotics. Pharmacotherapy. 13:(Suppl 2 pt 2):1993;4S-17S.
6. Performance Standards for Antimicrobial Disk Susceptibility Tests - Fifth Edition; Approved Standard M2-A5. 1993;NCCLS, Villanova, PA.
7. Performance Standards for Antimicrobial Susceptibility Testing; Eighth Informational Supplement M100-S8. 1998;NCCLS, Villanova, PA.
8. Neu H.C. Quinolone antimicrobial agents. Annu Rev Med. 43:1992;465-486.
9. Physicians' Desk Reference, 52nd ed (1998). Montvale, NJ: Medical Economics Co.
10. Piddock L.J. New quinolones and gram-positive bacteria. Antimicrob Agents Chemother. 38:1994;163-169.
11. Sefton A.M., Maskell J.P., Rafay A.M., Whiley A., Williams J.D. The in-vitro activity of trovafloxacin, a new fluoroquinolone, against gram-positive bacteria. J Antimicrob Chemother. 39:(suppl B):1997;57-62.
12. von Rosenstiel N., Adam D. Quinolone antibacterials. An update of their pharmacology and therapeutic use. Drugs. 47:1994;872-901.